Leonardo Geronzi
CEO & Co-founderEngineer, European PhD on medical digital twins for aneurysm treatment (H2020 MeDiTATe).
About us
Patient-specific cardiovascular models.
LivGemini is a medtech company based in Viterbo, Italy. The name joins living and gemini, the twins: a computational model built on the anatomy of one patient.
Mission
Make patient-specific models of the cardiovascular system, built from routine imaging with AI and physics, usable where care is assessed and planned. We start with the thoracic aorta.
Vision
Bring patient-specific cardiovascular models into the way patients are assessed and procedures are planned.
Team
Engineering, software and regulatory, in one team.
Andrea Baldini
CTO & Co-founderEngineer. Leads the development of the VenusX software platform.
Marco E. Biancolini
Co-founder, Business DevelopmentAssociate Professor of Machine Design, University of Rome Tor Vergata. Founder of RBF Morph.
Gaia De Angelis
Quality & Regulatory AffairsLeads the quality management system and regulatory planning.
Leonardo Ricchitelli
R&D EngineerComputational modelling and simulation.
Quality
Built like a medical device.
Quality system
LivGemini operates a quality management system certified to ISO 13485. Certification covers the management system; it is not an authorisation of the software.
Software life cycle
VenusX follows IEC 62304, with risk management, traceability and verification records for every release.
Regulatory path
Our objectives are a CE marking submission under the EU MDR and preparation for the FDA. VenusX is currently for research use only.
Funded projects
Research funded by European and national programmes.
PANDORA
Research on making cardiovascular digital twins faster to compute.
Funding details
- Coordinator
- LivGemini S.r.l.
- Funding
- €200,000
An HPC-, AI- and simulation-driven Digital Twin, built on clinical data and synthetic anatomies, for preoperative planning and graft selection in aortic aneurysm surgery.
SafeBot4Twin
A cyber-secure AI assistant to build and control in-silico models in natural language, with RBF Morph and the University of Rome Tor Vergata.
Funding details
- Coordinator
- RBF Morph S.r.l.
- Partner
- LivGemini S.r.l.
- Collaboration
- University of Rome Tor Vergata
- Total budget
- €309,994.33
- CYBER 4.0 co-financing
- €171,367.78
SafeBot4Twin is funded by the European Union – Next Generation EU (PNRR), Mission 4, Component 2, Investment 2.3.
Deep Tech Revolution
Support for the development of VenusX Flow.
Funding details
- CUP
- J95F21002190001
- COR
- 26003158
- Funding
- €142,556
VenusX Flow: a fast hemodynamic surrogate model that brings near-real-time, patient-specific blood flow predictions into the VenusX workflow.
Pre-Seed Plus
VenusX Diagnosis: development, clinical validation and market readiness of VenusX.
Funding details
- Coordinator
- LivGemini S.r.l.
- Total budget
- €62,148.00
- Lazio Innova financing
- €62,148.00
- CUP
- F88I26003740006
- COR
- 26050441
Expense charged to the FESR Lazio 2021–2027 Programme – PRE-SEED Plus Call, within the project “Venus X Diagnosis”: CUP F88I26003740006 – COR 26050441. Total expense allocated to the Project: €62,148.00.
Internationalisation Voucher
LivGemini International Expansion 2026: VenusX at EXPOsanità, MedtecLIVE and MEDICA.
Funding details
- Beneficiary
- LivGemini S.r.l.
- Project
- LivGemini International Expansion 2026
- CUP
- F88C26001110006
- Total public contribution
- €45,720.00
- Date of grant
- 23 April 2026
The project is supported by the PR FESR Lazio 2021–2027 under the call “Voucher Internazionalizzazione PMI 2026”.
Careers
Work with us.
We work on medical image analysis, AI, computational modelling and software for clinical use. There are no open positions right now, but we read every spontaneous application.
Spontaneous application · ref. LG-SA-2026
Send your CV and a few lines on what you would like to work on to info@livgemini.com.
Talk to the founders.
For investors and partners who want to know where LivGemini is going next.